Recurrent hepatocellular carcinoma cells with stem cell-like properties: possible targets for immunotherapy

References

• Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–6.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.
   PubMed Web of Science ®Google Scholar
• Bismuth H, Majno PE. Hepatobiliary surgery. J Hepatol. 2000;32:208–24.
   PubMed Web of Science ®Google Scholar
• Choi GH, Kim DH, Kang CM, Kim KS, Choi JS, Lee WJ, . Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma. Ann Surg Oncol. 2008;15:618–29.
   Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–11.
   PubMed Web of Science ®Google Scholar
• Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005;5:275–84.
   PubMed Web of Science ®Google Scholar
• Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea – a paradigm shift. Cancer Res. 2006;66:1883–90; discussion 95–6.
   PubMed Web of Science ®Google Scholar
• Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, . Cancer stem cells: perspectives on current status and future directions. AACR Workshop on cancer stem cells. Cancer Res. 2006;66:9339–44.
   PubMedGoogle Scholar
• Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730–7.
   PubMed Web of Science ®Google Scholar
• Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, . Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63:5821–8.
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983–8.
   PubMed Web of Science ®Google Scholar
• O’Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445:106–10.
   PubMed Web of Science ®Google Scholar
• Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, . Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445:111–5.
   PubMed Web of Science ®Google Scholar
• Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, . Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology. 2006;44:240–51.
   PubMed Web of Science ®Google Scholar
• Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, . Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology. 2007;132:2542–56.
   PubMed Web of Science ®Google Scholar
• Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, . Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell. 2008;13:153–66.
   PubMed Web of Science ®Google Scholar
• Wulf GG, Wang RY, Kuehnle I, Weidner D, Marini F, Brenner MK, . A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood. 2001;98:1166–73.
   PubMed Web of Science ®Google Scholar
• Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res. 2008;10:R25.
   PubMed Web of Science ®Google Scholar
• Todaro MAM, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, . Colon cancer stem cells dictate tumor growth and resist cell death by production of inter-leukin-4. Cell Stem Cell. 2007;1:353–5.
   Google Scholar
• Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756–60.
   PubMed Web of Science ®Google Scholar
• Engelmann K, Shen H, Finn OJ. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res. 2008;68:2419–26.
   PubMed Web of Science ®Google Scholar
• Pellegatta S, Poliani PL, Corno D, Menghi F, Ghielmetti F, Suarez-Merino B, . Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res. 2006;66:10247–52.
   PubMed Web of Science ®Google Scholar
• Wu A, Wiesner S, Xiao J, Ericson K, Chen W, Hall WA, . Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy. J Neurooncol. 2007;83:121–31.
   PubMed Web of Science ®Google Scholar
• Todaro M, D’Asaro M, Caccamo N, Iovino F, Francipane MG, Meraviglia S, . Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. J Immunol. 2009;182:7287–96.
   PubMed Web of Science ®Google Scholar
• Dudley ME, Wunderlich JR, Shelton TE, Even J, Rosenberg SA. Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother. 2003;26:332–42.
   PubMed Web of Science ®Google Scholar
• Shintani Y, Yotsuyanagi H, Moriya K, Fujie H, Tsutsumi T, Takayama T, . The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C. Cancer. 2000;88:2478–86.
   Google Scholar
• Rubio V, Stuge TB, Singh N, Betts MR, Weber JS, Roederer M, . Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med. 2003;9:1377–82.
   PubMed Web of Science ®Google Scholar
• Evarts RP, Nagy P, Marsden E, Thorgeirsson SS. A precursor–product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis. 1987;8:1737–40.
   PubMed Web of Science ®Google Scholar
• Lazaro CA, Rhim JA, Yamada Y, Fausto N. Generation of hepatocytes from oval cell precursors in culture. Cancer Res. 1998;58:5514–22.
   PubMed Web of Science ®Google Scholar
• Alison MR, Lovell MJ. Liver cancer: the role of stem cells. Cell Prolif. 2005;38:407–21.
   PubMed Web of Science ®Google Scholar
• Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, . In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003;17:1253–70.
   PubMed Web of Science ®Google Scholar
• Reynolds BA, Tetzlaff W, Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci. 1992;12:4565–74.
   PubMed Web of Science ®Google Scholar
• Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, . Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007;131:1109–23.
   PubMed Web of Science ®Google Scholar
• Rich BSAJ. Chemotherapy and cancer stem cells. Cell Stem Cell. 2007;1:353–5.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen H, Wu M, Bao J, Cong W, Wang H. Postoperative immunotherapy for patients with hepatocarcinoma using tumor-infiltrating lymphocytes. Chin Med J. 1997;110:114–7.
   Google Scholar
• Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, . Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet. 2000;356:802–7.
   PubMed Web of Science ®Google Scholar
• Thimme R, Neagu M, Boettler T, Neumann-Haefelin C, Kersting N, Geissler M, . Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma. Hepatology. 2008;48:1821–33.
   PubMed Web of Science ®Google Scholar
• Khong HT, Restifo NP. Natural selection of tumor variants in the generation of ‘tumor escape’ phenotypes. Nat Immunol. 2002;3:999–1005.
   PubMed Web of Science ®Google Scholar
• Um SH, Mulhall C, Alisa A, Ives AR, Karani J, Williams R, . Alpha-fetoprotein impairs APC function and induces their apoptosis. J Immunol. 2004;173:1772–8.
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Hiraoka N, Yamagami W, Ojima H, Kanai Y, Kosuge T, . FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res. 2007;13:902–11.
   PubMed Web of Science ®Google Scholar
• Reinisch W, Holub M, Katz A, Herneth A, Lichtenberger C, Schoniger-Hekele M, . Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepato-cellular carcinoma. J Immunother. 2002;25:489–99.
   PubMedGoogle Scholar